IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Name: IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers
License: Public Domain

Hospices Civils de Lyon

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

peritoneal mesothelioma, gestational trophoblastic tumor, thymoma and thymic carcinoma, anaplastic thyroid carcinomas, gastroenteropancreatic neuroendocrine tumor, carcinoid tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 140974
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.